Adding TNF-α or IFN-β to our assays, at levels comparable to those seen in HIV-positive (HIV+) patients with cryptococcal meningitis (24, –, 26), yielded small but significant changes in barrier permeability (Fig. 3F and G), consistent with those reports. This evidence concerns the gene TNF and Cryptococcal meningitis.